Treasurer of the State of North Carolina’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-22,524
Closed -$1.16M 1035
2021
Q1
$1.16M Sell
22,524
-60
-0.3% -$2.97K 0.01% 929
2020
Q4
$979K Buy
22,584
+60
+0.3% +$2.37K 0.01% 942
2020
Q3
$788K Sell
22,524
-20
-0.1% -$877 0.01% 932
2020
Q2
$1.21M Sell
22,544
-2,255
-9% -$104K 0.01% 849
2020
Q1
$880K Buy
24,799
+10,300
+71% +$476K 0.01% 848
2019
Q4
$692K Buy
14,499
+2,160
+18% +$81.6K 0.01% 906
2019
Q3
$400K Sell
12,339
-12,550
-50% -$520K ﹤0.01% 968
2019
Q2
$1.24M Buy
24,889
+4,430
+22% +$237K 0.01% 926
2019
Q1
$1.38M Buy
20,459
+173
+0.9% +$10.1K 0.01% 871
2018
Q4
$935K Buy
20,286
+273
+1% +$16.9K 0.01% 923
2018
Q3
$1.54M Buy
20,013
+8,304
+71% +$668K 0.01% 874
2018
Q2
$986K Buy
11,709
+6,760
+137% +$590K 0.01% 868
2018
Q1
$405K Buy
+4,949
New +$383K 0.01% 880

Other funds holding AGIO

Treasurer of the State of North Carolina's AGIO Position: Q2 2021 in Review

Treasurer of the State of North Carolina sold out of Agios Pharmaceuticals (AGIO) in Q2 2021, closing a stake of 22,524 shares — an estimated $1.16M sold.

Treasurer of the State of North Carolina first reported a position in AGIO in Q1 2018 and held it in 13 quarters. The position peaked at $1.54M in Q3 2018. 186 funds tracked by Wall St. Rank hold AGIO as of Q2 2021.

  • Treasurer of the State of North Carolina reported no remaining Agios Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 22,524 Agios Pharmaceuticals shares in Q2 2021, an estimated $1.16M.
  • Treasurer of the State of North Carolina first reported a position in Agios Pharmaceuticals in Q1 2018 and held it in 13 quarters.
  • Treasurer of the State of North Carolina's Agios Pharmaceuticals position peaked at $1.54M in Q3 2018.
  • 186 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2021.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2021, filed 13 Aug 2021.